ID   LX12B_RAT               Reviewed;         701 AA.
AC   Q2KMM4; Q2KMM5;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 1.
DT   24-JAN-2024, entry version 97.
DE   RecName: Full=Arachidonate 12-lipoxygenase, 12R-type {ECO:0000305};
DE            Short=12R-LOX;
DE            Short=12R-lipoxygenase;
DE            EC=1.13.11.- {ECO:0000269|PubMed:23382512};
DE   AltName: Full=Epidermis-type lipoxygenase 12;
GN   Name=Alox12b {ECO:0000312|RGD:1305330};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:AAX85363.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Brown Norway/Cub, SHR/OlaIpcv {ECO:0000312|EMBL:AAX85363.1}, and
RC   Wistar Hd; TISSUE=Testis {ECO:0000312|EMBL:AAX85363.1};
RX   PubMed=15222128;
RA   Liska F., Goesele C., Kren V., Huebner N., Krenova D.;
RT   "Molecular analysis of the sex hormone-binding globulin gene in the rat
RT   hypodactylous mutation (Hd).";
RL   Folia Biol. (Praha) 50:63-68(2004).
RN   [2]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23382512; DOI=10.1096/fj.12-217414;
RA   Gregus A.M., Dumlao D.S., Wei S.C., Norris P.C., Catella L.C.,
RA   Meyerstein F.G., Buczynski M.W., Steinauer J.J., Fitzsimmons B.L.,
RA   Yaksh T.L., Dennis E.A.;
RT   "Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical
RT   role for spinal eLOX3 hepoxilin synthase activity in inflammatory
RT   hyperalgesia.";
RL   FASEB J. 27:1939-1949(2013).
CC   -!- FUNCTION: Catalyzes the regio and stereo-specific incorporation of a
CC       single molecule of dioxygen into free and esterified polyunsaturated
CC       fatty acids generating lipid hydroperoxides that can be further reduced
CC       to the corresponding hydroxy species (PubMed:23382512). In the skin,
CC       acts upstream of ALOXE3 on the lineolate moiety of esterified omega-
CC       hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone
CC       derivative, a crucial step in the conjugation of omega-hydroxyceramide
CC       to membrane proteins. Therefore plays a crucial role in the synthesis
CC       of corneocytes lipid envelope and the establishment of the skin barrier
CC       to water loss. May also play a role in the regulation of the expression
CC       of airway mucins (By similarity). {ECO:0000250|UniProtKB:O75342,
CC       ECO:0000269|PubMed:23382512}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (12R)-hydroperoxy-
CC         (5Z,8Z,10E,14Z)-eicosatetraenoate; Xref=Rhea:RHEA:41336,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32395, ChEBI:CHEBI:75230;
CC         Evidence={ECO:0000269|PubMed:23382512};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41337;
CC         Evidence={ECO:0000305|PubMed:23382512};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-[omega-(9Z,12Z)-octadecadienoyloxy]acyl-beta-D-glucosyl-
CC         (1<->1)-octadecasphing-4E-enine + O2 = N-[omega-(9R)-hydroperoxy-
CC         (10E,12Z)-octadecadienoyloxy]acyl-beta-D-glucosyl-(1<->1)-
CC         octadecasphing-4E-enine; Xref=Rhea:RHEA:40495, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:134621, ChEBI:CHEBI:134624;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40496;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-[omega-(9Z,12Z)-octadecadienoyloxy]-acylsphin-4-enine + O2 =
CC         N-acyl (9R)-hydroperoxy-(10E,12Z)-octadecadienoate octadecasphing-4E-
CC         enine; Xref=Rhea:RHEA:41239, ChEBI:CHEBI:15379, ChEBI:CHEBI:77888,
CC         ChEBI:CHEBI:77889; Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41240;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z)-octadecatrienoate + O2 = 10-hydroperoxy-
CC         (6Z,8E,12Z)-octadecatrienoate; Xref=Rhea:RHEA:43476,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32391, ChEBI:CHEBI:83342;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43477;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 = 14-
CC         hydroperoxy-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoate;
CC         Xref=Rhea:RHEA:43472, ChEBI:CHEBI:15379, ChEBI:CHEBI:77016,
CC         ChEBI:CHEBI:83336; Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43473;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z)-eicosatrienoate + O2 = (8Z,10E,14Z)-12-
CC         hydroperoxyeicosatrienoate; Xref=Rhea:RHEA:43468, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:71589, ChEBI:CHEBI:83334;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43469;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 =
CC         (5Z,7Z,8Z,10E,14Z,17Z)-12-hydroperoxyeicosapentaenoate;
CC         Xref=Rhea:RHEA:41344, ChEBI:CHEBI:15379, ChEBI:CHEBI:58562,
CC         ChEBI:CHEBI:78078; Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41345;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z)-octadecatrienoate + O2 = 10R-hydroperoxy-
CC         (6Z,8E,12Z)-octadecatrienoate; Xref=Rhea:RHEA:41340,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32391, ChEBI:CHEBI:78070;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41341;
CC         Evidence={ECO:0000250|UniProtKB:O75342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = 1-O-methyl
CC         (5Z,8Z,10E,12R,14Z)-hydroperoxyiecosatetraenoate;
CC         Xref=Rhea:RHEA:41311, ChEBI:CHEBI:15379, ChEBI:CHEBI:78033,
CC         ChEBI:CHEBI:78034; Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41312;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = 1-O-
CC         methyl-8-hydroperoxy-(5Z,9E,11Z,14Z)-eicosatetraenoate;
CC         Xref=Rhea:RHEA:43480, ChEBI:CHEBI:15379, ChEBI:CHEBI:78033,
CC         ChEBI:CHEBI:83344; Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43481;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = 1-O-
CC         methyl-(8R)-hydroperoxy-(5Z,9E,11Z,14Z)-eicosatrienoate;
CC         Xref=Rhea:RHEA:61868, ChEBI:CHEBI:15379, ChEBI:CHEBI:78033,
CC         ChEBI:CHEBI:78180; Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61869;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-(9Z,12Z)-octadecadienoate + O2 = 1-O-methyl-(9R)-
CC         hydroperoxy-(10E,12Z)-octadecadienoate; Xref=Rhea:RHEA:61872,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:69080, ChEBI:CHEBI:145036;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61873;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-20-hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 =
CC         1-O-methyl-8-hydroperoxy-20-hydroxy-(5Z,9E,11Z,14Z)-
CC         eicosatetraenoate; Xref=Rhea:RHEA:61876, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:145032, ChEBI:CHEBI:145033;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61877;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-20-hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 =
CC         1-O-methyl-12-hydroperoxy-20-hydroxy-(5Z,8Z,10E,14Z)-
CC         eicosatetraenoate; Xref=Rhea:RHEA:61880, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:145032, ChEBI:CHEBI:145034;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61881;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-20-hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 =
CC         1-O-methyl-9-hydroperoxy-20-hydroxy-(5Z,7E,11Z,14Z)-
CC         eicosatetraenoate; Xref=Rhea:RHEA:61884, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:145032, ChEBI:CHEBI:145035;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61885;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-methyl-(9Z,12Z)-octadecadienoate + O2 = 1-O-methyl-(13S)-
CC         hydroperoxy-(9Z,11E)-octadecadienoate; Xref=Rhea:RHEA:41756,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:69080, ChEBI:CHEBI:78040;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41757;
CC         Evidence={ECO:0000250|UniProtKB:O70582};
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00726};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00726};
CC   -!- ACTIVITY REGULATION: Increased by calcium.
CC       {ECO:0000250|UniProtKB:O70582}.
CC   -!- PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid
CC       biosynthesis.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|PROSITE-ProRule:PRU00726}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:O75342}.
CC   -!- SIMILARITY: Belongs to the lipoxygenase family. {ECO:0000255}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=about water - Issue 153 of
CC       September 2013;
CC       URL="https://web.expasy.org/spotlight/back_issues/153/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY903231; AAX85361.1; -; mRNA.
DR   EMBL; AY903232; AAX85362.1; -; mRNA.
DR   EMBL; AY903233; AAX85363.1; -; mRNA.
DR   RefSeq; NP_001034466.1; NM_001039377.1.
DR   AlphaFoldDB; Q2KMM4; -.
DR   SMR; Q2KMM4; -.
DR   STRING; 10116.ENSRNOP00000033009; -.
DR   PhosphoSitePlus; Q2KMM4; -.
DR   PaxDb; 10116-ENSRNOP00000033009; -.
DR   Ensembl; ENSRNOT00055056392; ENSRNOP00055046498; ENSRNOG00055032640.
DR   Ensembl; ENSRNOT00060035699; ENSRNOP00060029361; ENSRNOG00060020609.
DR   GeneID; 287425; -.
DR   KEGG; rno:287425; -.
DR   UCSC; RGD:1305330; rat.
DR   AGR; RGD:1305330; -.
DR   CTD; 242; -.
DR   RGD; 1305330; Alox12b.
DR   eggNOG; ENOG502SJSP; Eukaryota.
DR   InParanoid; Q2KMM4; -.
DR   OrthoDB; 999249at2759; -.
DR   PhylomeDB; Q2KMM4; -.
DR   Reactome; R-RNO-2142712; Synthesis of 12-eicosatetraenoic acid derivatives.
DR   UniPathway; UPA00222; -.
DR   UniPathway; UPA00881; -.
DR   PRO; PR:Q2KMM4; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0106237; F:arachidonate 12(R)-lipoxygenase activity; IEA:RHEA.
DR   GO; GO:0004052; F:arachidonate 12(S)-lipoxygenase activity; ISS:UniProtKB.
DR   GO; GO:0047677; F:arachidonate 8(R)-lipoxygenase activity; ISO:RGD.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:1990136; F:linoleate 9S-lipoxygenase activity; ISS:UniProtKB.
DR   GO; GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; ISO:RGD.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0061436; P:establishment of skin barrier; ISS:UniProtKB.
DR   GO; GO:0051122; P:hepoxilin biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0034440; P:lipid oxidation; IBA:GO_Central.
DR   GO; GO:0019372; P:lipoxygenase pathway; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0070257; P:positive regulation of mucus secretion; ISS:UniProtKB.
DR   GO; GO:0006497; P:protein lipidation; ISS:UniProtKB.
DR   GO; GO:0006665; P:sphingolipid metabolic process; ISS:UniProtKB.
DR   CDD; cd01753; PLAT_LOX; 1.
DR   Gene3D; 3.10.450.60; -; 1.
DR   Gene3D; 2.60.60.20; PLAT/LH2 domain; 1.
DR   InterPro; IPR000907; LipOase.
DR   InterPro; IPR013819; LipOase_C.
DR   InterPro; IPR036226; LipOase_C_sf.
DR   InterPro; IPR020834; LipOase_CS.
DR   InterPro; IPR020833; LipOase_Fe_BS.
DR   InterPro; IPR001885; LipOase_mml.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR042062; PLAT_LOX_verte.
DR   PANTHER; PTHR11771:SF40; ARACHIDONATE 12-LIPOXYGENASE, 12R-TYPE; 1.
DR   PANTHER; PTHR11771; LIPOXYGENASE; 1.
DR   Pfam; PF00305; Lipoxygenase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PRINTS; PR00087; LIPOXYGENASE.
DR   PRINTS; PR00467; MAMLPOXGNASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; Lipase/lipooxygenase domain (PLAT/LH2 domain); 1.
DR   SUPFAM; SSF48484; Lipoxigenase; 1.
DR   PROSITE; PS00711; LIPOXYGENASE_1; 1.
DR   PROSITE; PS00081; LIPOXYGENASE_2; 1.
DR   PROSITE; PS51393; LIPOXYGENASE_3; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Dioxygenase; Fatty acid metabolism; Iron; Lipid metabolism;
KW   Metal-binding; Oxidoreductase; Reference proteome.
FT   CHAIN           1..701
FT                   /note="Arachidonate 12-lipoxygenase, 12R-type"
FT                   /id="PRO_0000244486"
FT   DOMAIN          2..119
FT                   /note="PLAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DOMAIN          120..701
FT                   /note="Lipoxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         398
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         403
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         578
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         582
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         701
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   CONFLICT        276
FT                   /note="H -> L (in Ref. 1; AAX85362)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   701 AA;  80741 MW;  6BE209D98DEB4DB9 CRC64;
     MATYKVKVAT GTDFFSGTLD SISLTIVGTQ GESHKQRLNH FGRDFATGAV DDYTVQCQQD
     LGELIIIRLH KEPHSFLPKD PWYCNYVQIC APNCRVYHFP AYQWMDGYET LSLREATGKT
     TADDTLPILL EHRQEEIRAK KDFYHWRVFV PGLPNYVDIP SYHPPPRRCR NPNRPEWNGY
     IPGFPILINI KATRFLNLNL RFSFVKTASF FYRLGPMALA FKLRGLVDRK RSWKRLKDIK
     NIFPATKTVV SEYVAEHWTE DSFFGYQYLN GINPGHIRRC MQIPDKFPVT DEMVAPFLGE
     GTCLQAELEK GNIYLADYRI LDGIPTVELN GQKQHHCAPI CLLHFGPDGN MMPIAIQLSQ
     TPGPDCPIFL PNDSEWDWLL AKTWVRYAEF YSHEAVAHLL ESHLIGEAFC LALLRNLPMC
     HPLYKLLIPH TRYNVQINSI GRALLLNKGG LSARAMSLGL EGFAQVMVRG LSELTYKSLC
     IPNDFVERGV QDLPGYYFRD DSLAVWYAME RYVTEIITYY YPNDAAVEGD PELQCWVQEI
     FKECLLERES SGFPTCLRTV PELIEYVTMV MYTCSARHAA VNTGQLEYTS WMPNFPSSMR
     NPPMQSKGLT TLQTFMDTLP DVKTTCIVLL VLWTLCREPD DRRPLGHFPD IHFVEEAPRR
     SMEAFRQNLN QISHNIRQRN KCLNLPYYYL DPVLIENSIS I
//
